Systematic review reveals prevalence of occult nodal metastases in non-metastatic lung cancer, suggesting staging benefits.
This is the first published systematic review to evaluate the prevalence of PET-occult nodal disease in non-metastatic NSCLC using systematic staging EBUS-TBNA. Approximately 1 in 12 patients were identified to have PET-occult nodal metastases. These findings support the routine implementation of systematic endoscopic staging to guide curative-intent treatment decisions across non-metastatic disease stages.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: